Libby P

Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis.

Uddin MM, Saadatagah S, Niroula A, ..., Ballantyne CM, Natarajan P

Nat Commun 15 (1) 7858 [2024-09-09; online 2024-09-09]

Abhishek Niroula DDLS Fellow

Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.

Lin AE, Bapat AC, Xiao L, ..., Ellinor PT, Ebert BL

Circulation 149 (18) 1419-1434 [2024-04-30; online 2024-02-15]

Abhishek Niroula DDLS Fellow

Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.

Schuermans A, Vlasschaert C, Nauffal V, ..., Natarajan P, Honigberg MC

Eur. Heart J. 45 (10) 791-805 [2024-03-07; online 2023-11-12]

Abhishek Niroula DDLS Fellow

Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.

Bhattacharya R, Uddin MM, Patel AP, ..., Grinspoon SK, Natarajan P

Blood Adv 8 (4) 959-967 [2024-02-27; online 2024-01-10]

Abhishek Niroula DDLS Fellow

Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.

Yu Z, Fidler TP, Ruan Y, ..., Tall AR, Natarajan P

J. Clin. Invest. 133 (18) - [2023-09-15; online 2023-09-15]

Abhishek Niroula DDLS Fellow

Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.

Nakao T, Bick AG, Taub MA, ..., NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium , Natarajan P

Sci Adv 8 (14) eabl6579 [2022-04-08; online 2022-04-06]

Abhishek Niroula DDLS Fellow